Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 7/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | EEF2K | O00418 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
| ▸ | TYK2 | P29597 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7823148 | 0.87 | PDE2A (0.63) | PDE2ACYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL28308850 | 0.81 | PDE2A (0.44) | PDE2ACYP1A2CES2ALDH1A1MAPT | |
| SCHEMBL6644323 | 0.78 | PDE2A (0.65) | PDE2ACYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL18075371 | 0.77 | PDE2A (1.00) | PDE2ACYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL11321093 | 0.77 | TP53 (0.47) | ALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL4633442 | 0.77 | PDE2A (0.63) | PDE2ACYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL4633445 | 0.77 | PDE2A (0.63) | PDE2ACYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL19914016 | 0.74 | PDE2A (0.59) | PDE2ACYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL22279498 | 0.74 | PDE2A (0.59) | PDE2AALDH1A1KDM4EMRGPRX4LMNA | |
| SCHEMBL29472442 | 0.74 | PDE2A (0.59) | PDE2AALDH1A1KDM4EMRGPRX4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7183238-B2 | [1,2]-oxazine-3,5-diones | BAYER CROPSCIENCE AG (DE) | 2007-02-27 | — | — | US | disclosed |
| US-20050070707-A1 | microbicides, pesticides and herbicides | BAYER CROPSCIENCE AG (DE) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070707-A1 | microbicides, pesticides and herbicides | DDT, CX3CR1, MSR1 | PDE2A 661/4885CYP1A2 171/4885CYP2D6 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.